Novarex: Strong Q1 2026 results and share cancellation; subsidiary sale and EB overhang
-
Q1 2026 revenue of 120.8 billion won (+48.3% YoY), operating profit of 14.1 billion (margin 11.7%), net profit of 14.9 billion (margin 12.3%), showing significant earnings improvement.
KOSDAQ Filing Information
- Filing: Quarterly Report (2026.03)
- Company: NOVAREX (194700)
- Submission: NOVAREX Co., Ltd.
- Receipt: 05-15-2026